Form 4: Bioventus Inc. Executive D'Adamio Reports Stock Transactions
SEC Form 4 Filing
Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., reports the vesting of restricted stock units and subsequent acquisition of Class A Common Stock.
Summary
- On March 14, 2024, Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., reported a transaction involving restricted stock units.
- 8,886 restricted stock units vested, converting into 8,886 shares of Class A Common Stock.
- Following the transaction, D'Adamio directly owns 54,496 shares of Class A Common Stock and 17,772 restricted stock units.
- The restricted stock units vest in four approximately equal annual installments beginning on March 14, 2023.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive, with neutral sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| March 14, 2023 | Start date of the vesting schedule for the original grant of 35,545 RSUs. |
| March 14, 2024 | Date of the reported transaction: vesting of 8,886 restricted stock units and acquisition of Class A Common Stock. |
| March 18, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.